ArticleSmall science2026
Wearable Hybrid Strain-Myoelectric Sensing System for Machine-Learning-Assisted Sarcopenia Screening.
Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wearable Hybrid Strain-Myoelectric Sensing System for Machine-Learning-Assisted Sarcopenia Screening.Small science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The early screening of sarcopenia represents a critical clinical need amid the accelerating global aging population. Current diagnostic methods, relying on bioelectrical impedance analysis (BIA), handgrip strength testing, and other clinical examinations, depend on costly medical equipment and struggle to concurrently assess both muscle mass and strength. Herein, we propose a Wearable Sarcopenia Assessment System (WSAS), which employs an integrated hybrid surface electromyography (sEMG)-piezoelectric strain sensing platform to synchronously capture electrophysiological signals and mechanical deformation signals during muscle contraction in handgrip tests (signal-to-noise ratio: 34.32 dB), and incorporates a CNN-LSTM deep learning framework. This model was trained using nine physiologically relevant features (including root mean square (RMS), mean absolute value (MAV), and integrated EMG (iEMG)) extracted through feature engineering as prior knowledge. Validated in a cohort of 75 elderly participants, the proposed system achieved a screening accuracy of 99.85% with an area under the curve (AUC) of 0.97. Shapley additive explanations (SHAP)-based interpretability analysis further revealed that WSAS captures neuromuscular alterations associated with sarcopenia, including type II-to-type I muscle fiber transition and neuromuscular junction remodeling. These results demonstrate the potential of WSAS as a portable, low-cost, and radiation-free platform for early-stage sarcopenia screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.